Strategic changes in the pharmaceutical industry are focusing R&D efforts on new biologic medicines, with strong commercial pressures driving bioprocess development efforts towards greater productivity, with shorter timelines and reduced costs. High through-put technologies offer the possibility of achieving these goals, and in recent years many such technologies have been applied to bioprocessing. High through-put approaches can deliver better exploration of design space and improved process optimization, with a similar or even significantly reduced laboratory workload.
Exhibitors: Click to book your stand
Delegates: Click here to register for free